Brain injury often causes balance and gait impairments. Neuromodulation offers a noninvasive, time-limited way to restore or significantly improve balance.

Selective serotonin reuptake inhibitors (SSRIs) are considered the first-line, gold standard treatment for depression. However, their use is not without limitations, with commonly reported side ...

For poststroke neurogenic overactive bladder, low-frequency contralesional repetitive transcranial magnetic stimulation is safe and effective.

The Food and Drug Administration granted de novo approval to Modius Spero, marking it the world’s first neuromodulation device authorized to ...

Medtronic will acquire SPR Therapeutics for $650 million, adding the FDA-cleared SPRINT PNS System for temporary PNS to its ...

Patients with noncardioembolic ischemic stroke or transient ischemic attack (TIA) are at risk for recurrent stroke. Low factor XI levels are associated with a reduced risk of ischemic stroke.

Abstract: Stroke remains a significant global health challenge, imposing substantial socioeconomic burdens. Post-stroke neurorehabilitation aims to maximize functional recovery and mitigate persistent ...

A study led by a speech neuroscientist at The University of Texas at Dallas sheds light on how damage from stroke disrupts the brain mechanisms required for fluent speech. The research, published in ...

Post-stroke cognitive impairment (PSCI) substantially diminishes quality of life and functional independence in stroke survivors. Various non-pharmacological interventions have been proposed to ...

The risk of recurrent ischemic stroke can be reduced by managing modifiable risk factors and instituting a regimen of mechanism-specific secondary stroke prevention. Strategies for secondary ...

For many stroke survivors, recovery is derailed by painful muscle stiffness and involuntary spasms that limit movement, independence, and quality of life. Often viewed as an unavoidable consequence of ...

For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S. FDA enabling at-home use of neuromodulation devices may provide a bright ...